Addressing Cancer's Greatest Unmet Needs

Our lead candidate, ST101, is designed to promote cell death of hematologic malignancies and solid tumors, including acute myeloid leukemia (AML) and glioblastoma (GBM), two of the most deadly forms of cancer.

What makes ST101 Stand Out
Translating Science into Novel Therapeutics

Translating Science into Novel Therapeutics

Staying true to our name (Sapience, noun: Wisdom), we seek to develop well pedigreed science into much needed medicine.

Get to Know Us
Science Backed by Strong Leadership

Science Backed by Strong Leadership

Our world-class team is helping us pave the way to providing therapeutics for major unmet medical needs.

View Leadership
Promoting Tumor Cell Death

Promoting Tumor Cell Death

Our therapeutic candidates disrupt specific protein-protein interactions to directly and indirectly promote tumor cell death.

How ST101 Works